market is segmented as vaccine & therapeutics development, tissue and tissue-related products testing, blood
and blood-related products testing, stem cell research and cellular and gene therapy.
Make an Enquiry
https://www.infiniumglobalresearch.com/reports/enquiry/708
Geographies covered
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key trends and market size for each geography are provided over the
period of 2017 – 2023.
Globally, North America market dominated the world biologics safety testing market followed by Europe and
Asia-Pacific. Furthermore, Asia Pacific market is expected to grow at the highest CAGR over the forecast period
2017-2023. Due to the increasing emerging economies like china and India, growing population.
Companies Profiled:
The report provides profiles of the companies in the global biologics safety testing market such as, Toxikon
Corporation, Charles River Laboratories International, Inc., Avance Biosciences Inc., Thermo Fisher Scientific
Inc., Merck KGaA, Lonza Group Ltd., Pace Analytical Services Inc., Eurofins Scientific Se, Wuxi Apptec, Sartorius
AG, Cytovance Biologics, Inc.
Infinium Global Research